CLINICAL_TRIALS
trial_result
· 2021-11-11
Clinical Trial Update: A Phase II Study of BVD-523 in Metastatic Uveal Melanoma [Phase 2]
Summary
Phase II study of BVD-523 in metastatic uveal melanoma was terminated; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dana-Farber Cancer Institute | Conditions: Uveal Melanoma | Phase 2 | Status: TERMINATED | Results posted: 2021-11-11